Megace ES

Product NDC: 49884-949
11-digit product format: 498840949
Labeler code: 49884
Product ID: 49884-949_ad5147c4-60e0-442f-b4fd-41d1956d7724
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: megesterol acetate
Dosage form: SUSPENSION
Route: ORAL
Labeler: Par Pharmaceutical, Inc
Application: NDA021778
Marketing category: NDA
Marketing start: 2005-07-02
Marketing end: 0000-00-00
Substance: MEGESTROL ACETATE
Active strength: 125 mg/mL
Pharmacologic classes: Progesterone Congeners [CS],Progestin [EPC]
NDC exclude flag: E
Listing certified through: 2017-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	49884-949		D	Discontinued by firm		2026-08-10
excluded package	package	49884-949	49884-949-69	D	Discontinued by firm		2026-08-10

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 24 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	49884-949-69	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	49884-949-69	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	49884-949-69	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	49884-949-69	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	49884-949-69	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	49884-949-69	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	49884-949-69	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	49884-949-69	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	49884-949-69	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	49884-949-69	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	49884-949-69	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	49884-949-69	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N021778-001	MEGACE ES	MEGESTROL ACETATE	125MG/ML	SUSPENSION / ORAL		RLD	2005-07-05

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N021778-001	MEGACE ES	125MG/ML	SUSPENSION / ORAL		RLD	2005-07-05	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021778-001	MEGACE ES	125MG/ML	SUSPENSION / ORAL		RLD	2005-07-05	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N021778-001	MEGACE ES	125MG/ML	SUSPENSION / ORAL		RLD	2005-07-05	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021778-001	MEGACE ES	125MG/ML	SUSPENSION / ORAL		RLD	2005-07-05	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021778-001	MEGACE ES	125MG/ML	SUSPENSION / ORAL	AB	RLD, RS	2005-07-05	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021778-001	MEGACE ES	125MG/ML	SUSPENSION / ORAL	AB	RLD, RS	2005-07-05	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021778-001	MEGACE ES	125MG/ML	SUSPENSION / ORAL	AB	RLD, RS	2005-07-05	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021778-001	MEGACE ES	125MG/ML	SUSPENSION / ORAL	AB	RLD, RS	2005-07-05	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021778-001	MEGACE ES	125MG/ML	SUSPENSION / ORAL	AB	RLD, RS	2005-07-05	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N021778-001	MEGACE ES	125MG/ML	SUSPENSION / ORAL	AB	RLD, RS	2005-07-05	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021778-001	MEGACE ES	125MG/ML	SUSPENSION / ORAL	AB	RLD, RS	2005-07-05	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021778-001	MEGACE ES	125MG/ML	SUSPENSION / ORAL	AB	RLD, RS	2005-07-05	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021778-001	MEGACE ES	125MG/ML	SUSPENSION / ORAL	AB	RLD, RS	2005-07-05	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N021778-001	MEGACE ES	125MG/ML	SUSPENSION / ORAL	AB	RLD, RS	2005-07-05	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N021778-001	MEGACE ES	125MG/ML	SUSPENSION / ORAL	AB	RLD, RS	2005-07-05	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N021778-001	MEGACE ES	125MG/ML	SUSPENSION / ORAL	AB	RLD, RS	2005-07-05	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N021778-001	MEGACE ES	125MG/ML	SUSPENSION / ORAL	AB	RLD, RS	2005-07-05	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N021778-001	MEGACE ES	125MG/ML	SUSPENSION / ORAL	AB	RLD, RS	2005-07-05	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N021778-001	MEGACE ES	125MG/ML	SUSPENSION / ORAL	AB	RLD, RS	2005-07-05	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N021778-001	MEGACE ES	125MG/ML	SUSPENSION / ORAL	AB	RLD, RS	2005-07-05	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N021778-001	MEGACE ES	125MG/ML	SUSPENSION / ORAL	AB	RLD, RS	2005-07-05	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N021778-001	MEGACE ES	125MG/ML	SUSPENSION / ORAL	AB	RLD, RS	2005-07-05	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N021778-001	MEGACE ES	125MG/ML	SUSPENSION / ORAL	AB	RLD, RS	2005-07-05	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N021778-001	MEGACE ES	125MG/ML	SUSPENSION / ORAL	AB	RLD, RS	2005-07-05	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N021778-001	MEGACE ES	125MG/ML	SUSPENSION / ORAL	AB	RLD, RS	2005-07-05	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N021778-001	MEGACE ES	125MG/ML	SUSPENSION / ORAL	AB	RLD, RS	2005-07-05	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N021778-001	MEGACE ES	125MG/ML	SUSPENSION / ORAL	AB	RLD, RS	2005-07-05	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N021778-001	MEGACE ES	125MG/ML	SUSPENSION / ORAL	AB	RLD, RS	2005-07-05	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N021778-001	MEGACE ES	125MG/ML	SUSPENSION / ORAL	AB	RLD, RS	2005-07-05	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N021778-001	MEGACE ES	125MG/ML	SUSPENSION / ORAL	AB	RLD, RS	2005-07-05	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N021778-001	MEGACE ES	125MG/ML	SUSPENSION / ORAL	AB	RLD, RS	2005-07-05	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N021778-001	MEGACE ES	125MG/ML	SUSPENSION / ORAL	AB	RLD, RS	2005-07-05	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N021778-001	MEGACE ES	125MG/ML	SUSPENSION / ORAL	AB	RLD, RS	2005-07-05	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N021778-001	MEGACE ES	125MG/ML	SUSPENSION / ORAL	AB	RLD, RS	2005-07-05	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N021778-001	MEGACE ES	125MG/ML	SUSPENSION / ORAL	AB	RLD, RS	2005-07-05	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N021778-001	MEGACE ES	125MG/ML	SUSPENSION / ORAL	AB	RLD, RS	2005-07-05	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N021778-001	MEGACE ES	125MG/ML	SUSPENSION / ORAL	AB	RLD, RS	2005-07-05	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N021778-001	MEGACE ES	125MG/ML	SUSPENSION / ORAL	AB	RLD, RS	2005-07-05	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N021778-001	MEGACE ES	125MG/ML	SUSPENSION / ORAL	AB	RLD, RS	2005-07-05	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N021778-001	MEGACE ES	125MG/ML	SUSPENSION / ORAL	AB	RLD, RS	2005-07-05	`cb3db0bc1861…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021778-001	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021778-001	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021778-001	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021778-001	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021778-001	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N021778-001	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021778-001	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021778-001	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021778-001	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N021778-001	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N021778-001	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N021778-001	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N021778-001	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N021778-001	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N021778-001	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N021778-001	AB	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N021778-001	AB	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N021778-001	AB	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N021778-001	AB	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N021778-001	AB	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N021778-001	AB	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N021778-001	AB	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N021778-001	AB	1	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N021778-001	AB	1	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N021778-001	AB	1	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N021778-001	AB	1	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N021778-001	AB	1	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N021778-001	AB	1	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N021778-001	AB	1	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N021778-001	AB	1	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N021778-001	AB	1	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N021778-001	AB	1	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N021778-001	AB	1	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N021778-001	AB	1	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N021778-001	AB	1	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N021778-001	AB	1	`cb3db0bc1861…`

Observed Orange Book patent history#

Patent history page 1 of 5 · 181 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Use code	Coverage / status	Submission date	Source SHA-256
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021778-001	7101576	2024-04-22	U-755			`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021778-001	9040088	2024-04-22	U-755		2015-06-11	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021778-001	9101540	2024-04-22	U-755	Drug product	2015-08-13	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021778-001	9101549	2024-04-22	U-755		2015-08-13	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021778-001	9107827	2024-04-22	U-755		2015-08-27	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021778-001	7101576	2024-04-22	U-755			`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021778-001	9040088	2024-04-22	U-755		2015-06-11	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021778-001	9101540	2024-04-22	U-755	Drug product	2015-08-13	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021778-001	9101549	2024-04-22	U-755		2015-08-13	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021778-001	9107827	2024-04-22	U-755		2015-08-27	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021778-001	7101576	2024-04-22	U-755			`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021778-001	9040088	2024-04-22	U-755		2015-06-11	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021778-001	9101540	2024-04-22	U-755	Drug product	2015-08-13	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021778-001	9101549	2024-04-22	U-755		2015-08-13	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021778-001	9107827	2024-04-22	U-755		2015-08-27	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021778-001	7101576	2024-04-22	U-755			`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021778-001	9040088	2024-04-22	U-755		2015-06-11	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021778-001	9101540	2024-04-22	U-755	Drug product	2015-08-13	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021778-001	9101549	2024-04-22	U-755		2015-08-13	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021778-001	9107827	2024-04-22	U-755		2015-08-27	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N021778-001	7101576	2024-04-22	U-755			`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N021778-001	9040088	2024-04-22	U-755		2015-06-11	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N021778-001	9101540	2024-04-22	U-755	Drug product	2015-08-13	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N021778-001	9101549	2024-04-22	U-755		2015-08-13	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N021778-001	9107827	2024-04-22	U-755		2015-08-27	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021778-001	7101576	2024-04-22	U-755			`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021778-001	9040088	2024-04-22	U-755		2015-06-11	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021778-001	9101540	2024-04-22	U-755	Drug product	2015-08-13	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021778-001	9101549	2024-04-22	U-755		2015-08-13	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021778-001	9107827	2024-04-22	U-755		2015-08-27	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021778-001	7101576	2024-04-22	U-755			`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021778-001	9040088	2024-04-22	U-755		2015-06-11	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021778-001	9101540	2024-04-22	U-755	Drug product	2015-08-13	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021778-001	9101549	2024-04-22	U-755		2015-08-13	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021778-001	9107827	2024-04-22	U-755		2015-08-27	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021778-001	7101576	2024-04-22	U-755			`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021778-001	9040088	2024-04-22	U-755		2015-06-11	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021778-001	9101540	2024-04-22	U-755	Drug product	2015-08-13	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021778-001	9101549	2024-04-22	U-755		2015-08-13	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021778-001	9107827	2024-04-22	U-755		2015-08-27	`1e350fbaab3a…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
078c5235-b5d8-c448-12aa-7c7688d21da3	Product name	3	20180205
1bec0d29-4d8b-21df-403d-4848e3aaa3bc	Product name	2	20170725
056e8b65-29c9-affb-3d52-7651668fe36b	Product name	1	20140508

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
49884-949-69	ML - Milliliter	49884-949	ba4c731f-937b-43fb-9f89-ea0b581763dd	1	2013-02-13

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
MEGESTROL ACETATE	ACTIVE INGREDIENT	TJ2M0FR8ES	MEGACE ES (MEGESTEROL ACETATE) SUSPENSION [ATLANTIC BIOLOGICALS CORPS]	3
MEGESTROL	ACTIVE MOIETY	EA6LD1M70M	MEGACE ES (MEGESTEROL ACETATE) SUSPENSION [ATLANTIC BIOLOGICALS CORPS]	3
CITRIC ACID MONOHYDRATE	INACTIVE INGREDIENT	2968PHW8QP	MEGACE ES (MEGESTEROL ACETATE) SUSPENSION [ATLANTIC BIOLOGICALS CORPS]	3
DOCUSATE SODIUM	INACTIVE INGREDIENT	F05Q2T2JA0	MEGACE ES (MEGESTEROL ACETATE) SUSPENSION [ATLANTIC BIOLOGICALS CORPS]	3
HYPROMELLOSE 2208 (100 MPA.S)	INACTIVE INGREDIENT	B1QE5P712K	MEGACE ES (MEGESTEROL ACETATE) SUSPENSION [ATLANTIC BIOLOGICALS CORPS]	3
LEMON	INACTIVE INGREDIENT	24RS0A988O	MEGACE ES (MEGESTEROL ACETATE) SUSPENSION [ATLANTIC BIOLOGICALS CORPS]	3
LIME (CITRUS)	INACTIVE INGREDIENT	8CZS546954	MEGACE ES (MEGESTEROL ACETATE) SUSPENSION [ATLANTIC BIOLOGICALS CORPS]	3
SODIUM BENZOATE	INACTIVE INGREDIENT	OJ245FE5EU	MEGACE ES (MEGESTEROL ACETATE) SUSPENSION [ATLANTIC BIOLOGICALS CORPS]	3
SUCROSE	INACTIVE INGREDIENT	C151H8M554	MEGACE ES (MEGESTEROL ACETATE) SUSPENSION [ATLANTIC BIOLOGICALS CORPS]	3
TRISODIUM CITRATE DIHYDRATE	INACTIVE INGREDIENT	B22547B95K	MEGACE ES (MEGESTEROL ACETATE) SUSPENSION [ATLANTIC BIOLOGICALS CORPS]	3
WATER	INACTIVE INGREDIENT	059QF0KO0R	MEGACE ES (MEGESTEROL ACETATE) SUSPENSION [ATLANTIC BIOLOGICALS CORPS]	3
MEGESTROL ACETATE	ACTIVE INGREDIENT	TJ2M0FR8ES	MEGACE ES (MEGESTROL ACETATE ) SUSPENSION [STAT RX USA]	2
MEGESTROL	ACTIVE MOIETY	EA6LD1M70M	MEGACE ES (MEGESTROL ACETATE ) SUSPENSION [STAT RX USA]	2
MEGESTROL ACETATE	ACTIVE INGREDIENT	TJ2M0FR8ES	MEGACE ES (MEGESTEROL ACETATE) SUSPENSION [PHYSICIANS TOTAL CARE, INC.]	1
MEGESTROL	ACTIVE MOIETY	EA6LD1M70M	MEGACE ES (MEGESTEROL ACETATE) SUSPENSION [PHYSICIANS TOTAL CARE, INC.]	1
ALCOHOL	INACTIVE INGREDIENT	3K9958V90M	MEGACE ES (MEGESTEROL ACETATE) SUSPENSION [PHYSICIANS TOTAL CARE, INC.]	1
CITRIC ACID MONOHYDRATE	INACTIVE INGREDIENT	2968PHW8QP	MEGACE ES (MEGESTEROL ACETATE) SUSPENSION [PHYSICIANS TOTAL CARE, INC.]	1
DOCUSATE SODIUM	INACTIVE INGREDIENT	F05Q2T2JA0	MEGACE ES (MEGESTEROL ACETATE) SUSPENSION [PHYSICIANS TOTAL CARE, INC.]	1
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	MEGACE ES (MEGESTEROL ACETATE) SUSPENSION [PHYSICIANS TOTAL CARE, INC.]	1
SODIUM BENZOATE	INACTIVE INGREDIENT	OJ245FE5EU	MEGACE ES (MEGESTEROL ACETATE) SUSPENSION [PHYSICIANS TOTAL CARE, INC.]	1
SODIUM CITRATE	INACTIVE INGREDIENT	1Q73Q2JULR	MEGACE ES (MEGESTEROL ACETATE) SUSPENSION [PHYSICIANS TOTAL CARE, INC.]	1
SUCROSE	INACTIVE INGREDIENT	C151H8M554	MEGACE ES (MEGESTEROL ACETATE) SUSPENSION [PHYSICIANS TOTAL CARE, INC.]	1
WATER	INACTIVE INGREDIENT	059QF0KO0R	MEGACE ES (MEGESTEROL ACETATE) SUSPENSION [PHYSICIANS TOTAL CARE, INC.]	1

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
TJ2M0FR8ES	MEGESTROL ACETATE	595-33-5	MEGESTROL ACETATE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
885111	MEGACE ES 625 MG in 5 mL Oral Suspension	PSN	654854bc-f847-4e3b-a0a1-8716553460ac	3
577154	megestrol acetate 625 MG in 5 mL Oral Suspension	PSN	654854bc-f847-4e3b-a0a1-8716553460ac	3
885111	megestrol acetate 125 MG/ML Oral Suspension [Megace]	SBD	654854bc-f847-4e3b-a0a1-8716553460ac	3
577154	megestrol acetate 125 MG/ML Oral Suspension	SCD	654854bc-f847-4e3b-a0a1-8716553460ac	3
885111	Megace ES 125 MG/ML Oral Suspension	SY	654854bc-f847-4e3b-a0a1-8716553460ac	3
885111	Megace ES 625 MG per 5 ML Oral Suspension	SY	654854bc-f847-4e3b-a0a1-8716553460ac	3
577154	megestrol acetate 625 MG per 5 ML Oral Suspension	SY	654854bc-f847-4e3b-a0a1-8716553460ac	3
885111	MEGACE ES 625 MG in 5 mL Oral Suspension	PSN	33bc102c-31a3-4fd9-9702-c1193d7699a3	2
577154	megestrol acetate 625 MG in 5 mL Oral Suspension	PSN	33bc102c-31a3-4fd9-9702-c1193d7699a3	2
885111	megestrol acetate 125 MG/ML Oral Suspension [Megace]	SBD	33bc102c-31a3-4fd9-9702-c1193d7699a3	2
577154	megestrol acetate 125 MG/ML Oral Suspension	SCD	33bc102c-31a3-4fd9-9702-c1193d7699a3	2
885111	Megace ES 125 MG/ML Oral Suspension	SY	33bc102c-31a3-4fd9-9702-c1193d7699a3	2
885111	Megace ES 625 MG per 5 ML Oral Suspension	SY	33bc102c-31a3-4fd9-9702-c1193d7699a3	2
577154	megestrol acetate 625 MG per 5 ML Oral Suspension	SY	33bc102c-31a3-4fd9-9702-c1193d7699a3	2

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Megace ES	Atlantic Biologicals Corps	2014-03-18	HUMAN PRESCRIPTION DRUG LABEL	3
MEGACE ES (megestrol acetate oral suspension) suspension	Stat Rx USA	2009-10-27	HUMAN PRESCRIPTION DRUG LABEL	2